A Randomized Phase 3 Trail of Alimta (Pemetrexed) and Carboplatin vs Etoposide and Carboplatin in Extensive-stage Small Cell Lung Cancer

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/064/30/09

Funding

  • Eli Lilly and Company: $8,931.00